Erythrocytes containing arginine deiminase

A - Human Necessities – 61 – K

Patent

Rate now

  [ 0.00 ] – not rated yet Voters 0   Comments 0

Details

A61K 38/50 (2006.01) A61P 7/00 (2006.01)

Patent

CA 2606420

Use of erythrocytes containing arginine deirainase for the preparation of a medicinal product for lowering the plasma concentration of arginine in vivo. Said use relates in particular to the treatment of arginine-dependent tumors, such as hepatocarcinoma and malignant melanoma, or inhibition of the synthesis of nitric oxide, and the prevention and/or treatment of septic shock.

On utilise des érythrocytes contenant de l'arginine désiminase pour préparer un produit thérapeutique servant à réduire la concentration plasmatique d'arginine in vivo. Cette utilisation porte notamment sur le traitement des tumeurs dépendant de l'arginine, telles que l'hépatocarcinome et le mélanome malin, ou sur l'inhibition de la synthèse de l'oxyde nitrique, et sur la prévention et/ou le traitement du choc septique.

LandOfFree

Say what you really think

Search LandOfFree.com for Canadian inventors and patents. Rate them and share your experience with other people.

Rating

Erythrocytes containing arginine deiminase does not yet have a rating. At this time, there are no reviews or comments for this patent.

If you have personal experience with Erythrocytes containing arginine deiminase, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Erythrocytes containing arginine deiminase will most certainly appreciate the feedback.

Rate now

     

Profile ID: LFCA-PAI-O-1560412

  Search
All data on this website is collected from public sources. Our data reflects the most accurate information available at the time of publication.